vs
Side-by-side financial comparison of Evercore Inc. (EVR) and ResMed (RMD). Click either name above to swap in a different company.
ResMed is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.0× Evercore Inc.). ResMed runs the higher net margin — 27.6% vs 23.0%, a 4.6% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (100.3% vs 11.0%). Over the past eight quarters, Evercore Inc.'s revenue compounded faster (42.2% CAGR vs 7.8%).
Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.
EVR vs RMD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.4B |
| Net Profit | $322.7M | $392.6M |
| Gross Margin | — | 61.8% |
| Operating Margin | — | 34.6% |
| Net Margin | 23.0% | 27.6% |
| Revenue YoY | 100.3% | 11.0% |
| Net Profit YoY | 106.1% | 13.9% |
| EPS (diluted) | $7.20 | $2.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $1.4B | ||
| Q1 26 | $1.4B | $1.4B | ||
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $838.0M | $1.3B | ||
| Q1 25 | $699.0M | $1.3B | ||
| Q4 24 | $979.5M | $1.3B | ||
| Q3 24 | $738.4M | $1.2B |
| Q2 26 | — | $392.6M | ||
| Q1 26 | $322.7M | $398.7M | ||
| Q4 25 | $204.0M | $392.6M | ||
| Q3 25 | $144.6M | $348.5M | ||
| Q2 25 | $97.2M | $379.7M | ||
| Q1 25 | $146.2M | $365.0M | ||
| Q4 24 | $140.4M | $344.6M | ||
| Q3 24 | $78.4M | $311.4M |
| Q2 26 | — | 61.8% | ||
| Q1 26 | — | 62.2% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% |
| Q2 26 | — | 34.6% | ||
| Q1 26 | — | 34.9% | ||
| Q4 25 | 24.2% | 34.6% | ||
| Q3 25 | 20.8% | 33.4% | ||
| Q2 25 | 18.0% | 33.7% | ||
| Q1 25 | 16.0% | 33.0% | ||
| Q4 24 | 21.8% | 32.5% | ||
| Q3 24 | 16.7% | 31.6% |
| Q2 26 | — | 27.6% | ||
| Q1 26 | 23.0% | 27.9% | ||
| Q4 25 | 15.7% | 27.6% | ||
| Q3 25 | 13.8% | 26.1% | ||
| Q2 25 | 11.6% | 28.2% | ||
| Q1 25 | 20.9% | 28.3% | ||
| Q4 24 | 14.3% | 26.9% | ||
| Q3 24 | 10.6% | 25.4% |
| Q2 26 | — | $2.68 | ||
| Q1 26 | $7.20 | $2.74 | ||
| Q4 25 | $4.80 | $2.68 | ||
| Q3 25 | $3.41 | $2.37 | ||
| Q2 25 | $2.36 | $2.58 | ||
| Q1 25 | $3.48 | $2.48 | ||
| Q4 24 | $3.32 | $2.34 | ||
| Q3 24 | $1.86 | $2.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $663.8M |
| Stockholders' EquityBook value | — | $6.3B |
| Total Assets | — | $8.5B |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $1.4B | ||
| Q1 26 | — | $1.7B | ||
| Q4 25 | $3.0B | $1.4B | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.4B | $932.7M | ||
| Q4 24 | $2.4B | $521.9M | ||
| Q3 24 | $1.8B | $426.4M |
| Q2 26 | — | $663.8M | ||
| Q1 26 | — | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
| Q2 26 | — | $6.3B | ||
| Q1 26 | — | $6.5B | ||
| Q4 25 | $2.0B | $6.3B | ||
| Q3 25 | $1.8B | $6.1B | ||
| Q2 25 | $1.7B | $6.0B | ||
| Q1 25 | $1.5B | $5.5B | ||
| Q4 24 | $1.7B | $5.3B | ||
| Q3 24 | $1.6B | $5.2B |
| Q2 26 | — | $8.5B | ||
| Q1 26 | — | $8.8B | ||
| Q4 25 | $5.4B | $8.5B | ||
| Q3 25 | $4.4B | $8.3B | ||
| Q2 25 | $3.7B | $8.2B | ||
| Q1 25 | $3.3B | $7.6B | ||
| Q4 24 | $4.2B | $7.1B | ||
| Q3 24 | $3.6B | $7.2B |
| Q2 26 | — | 0.11× | ||
| Q1 26 | — | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVR
| Advisory Fees (1) | $1.2B | 89% |
| Commissions and Related Revenue | $62.7M | 4% |
| Underwriting Fees | $55.1M | 4% |
| Asset Management and Administration Fees (2) | $23.7M | 2% |
| Other Revenue, net | $15.4M | 1% |
RMD
Segment breakdown not available.
